38 development-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"Inria" Fellowship positions at Center for Drug Evaluation and Research (CDER)

FDA Postdoctoral Fellowship - Biopredictive Dissolution Development for Oral Peptides

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 2 months ago

Skip to main content FDA Postdoctoral Fellowship - Biopredictive Dissolution Development for Oral Peptides Organization U.S. Food and Drug Administration (FDA) Reference Code FDA-CDER-2026-0125 How

FDA Fellowship - Integrated Clinical Trial Database Development for Drug Safety

Center for Drug Evaluation and Research (CDER) | Southern Md Facility, Maryland | United States | about 2 months ago

Clinical Trial Database Development for Drug Safety Organization U.S. Food and Drug Administration (FDA) Reference Code FDA-CDER-2026-0056 How to Apply To submit your application, scroll to the bottom

FDA Fellowship - Applied Regulatory Science In Vitro Molecular Assay Development

Center for Drug Evaluation and Research (CDER) | Southern Md Facility, Maryland | United States | 24 days ago

Skip to main content FDA Fellowship - Applied Regulatory Science In Vitro Molecular Assay Development Organization U.S. Food and Drug Administration (FDA) Reference Code FDA-CDER-2026-0116 How to

FDA Fellowship in Development and Control of Cell Free Manufacturing Platform Technologies

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 17 hours ago

Development and Control of Cell Free Manufacturing Platform Technologies Organization U.S. Food and Drug Administration (FDA) Reference Code FDA-CDER-2026-0174 How to Apply To submit your application, scroll

FDA Fellowship in Quantitative Regulatory Science: Integrating Nonclinical and Clinical Data to Support Targeted Therapy Development

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 17 hours ago

Quantitative Regulatory Science: Integrating Nonclinical and Clinical Data to Support Targeted Therapy Development Organization U.S. Food and Drug Administration (FDA) Reference Code FDA-CDER-2026-0180 How

FDA Fellowship - Digital Health Technologies in Drug Development: Endpoint Analysis, Regulatory Guidance Comparison, and Systematic Literature Review

Center for Drug Evaluation and Research (CDER) | Naidu Vari Palem, Andhra Pradesh | India | 2 months ago

Health Technologies in Drug Development: Endpoint Analysis, Regulatory Guidance Comparison, and Systematic Literature Review Organization U.S. Food and Drug Administration (FDA) Reference Code FDA

FDA Fellowship: Food Effect Evaluation for Oncology Drugs

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 17 hours ago

guidance.  You will have the opportunity to contribute to advancing FDA's mission of protecting and promoting public health through evidence-based regulatory decision-making in oncology drug development

FDA Statistical Fellowship

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 17 hours ago

the Office of Translational Sciences at the FDA is recognized for excellence in the application and communication of statistical science in drug regulation and development. We play a central role in

FDA Fellowship - Applied Regulatory Science in Bioinformatics and Omics Biomarker Discovery

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 17 hours ago

approaches to develop biomarkers that can serve as qualified regulatory tools, supporting standardized endpoints for drug development and informed regulatory decision-making.   This fellowship represents an

FDA Modeling and Simulation Fellowships

Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 17 hours ago

include providing quantitative method support for guidance development, abbreviated new drug application (ANDA) reviews, citizen petitions, controlled correspondence, pre-ANDA meetings, methodology